The Use of Infliximab for Treatment of Hospitalized Patients with Acute Severe Ulcerative Colitis
Author(s) -
Brian Bressler,
JK Law,
N Al Nahdi Sheraisher,
Kenneth G. Atkinson,
MF Byrne,
HV Chung,
Martin Fishman,
N. Partovi,
Douglas C. Pearson,
Reginald M. Penner,
RA Enns
Publication year - 2008
Publication title -
canadian journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1916-7237
pISSN - 0835-7900
DOI - 10.1155/2008/749547
Subject(s) - infliximab , medicine , ulcerative colitis , colectomy , azathioprine , demographics , refractory (planetary science) , surgery , disease , demography , sociology , physics , astrobiology
The use of infliximab in severe ulcerative colitis (UC) is established; however, its role in severe acute UC requires clarification. The present multicentre case series evaluated infliximab in hospitalized patients with steroid-refractory severe UC.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom